AN2 Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ACRV
Acrivon Therapeutics, Inc. Common Stock |
$5.56 | $223.86 M | -2.51 | 58 | $0 |
ADAG
Adagene Inc. |
$1.84 | $131.46 M | -6.77 | 174 | $18.11 M |
ANEB
Anebulo Pharmaceuticals, Inc. |
$1.62 | $56.28 M | -5.86 | 2 | $0 |
AVTE
Aerovate Therapeutics, Inc. |
$2.43 | $597.48 M | -6.84 | 51 | $0 |
ELYM
Eliem Therapeutics, Inc. |
$5.11 | $258.33 M | -17.08 | 9 | $0 |
MLYS
Mineralys Therapeutics, Inc. |
$9.51 | $652.38 M | -6.03 | 28 | $0 |
MNOV
MediciNova, Inc. |
$1.87 | $67.19 M | -8.06 | 13 | $1.00 M |
MOLN
Molecular Partners AG |
$5.81 | $135.05 M | -2.03 | 167 | $7.04 M |
PEPG
PepGen Inc. |
$2.41 | $537.15 M | -5.11 | 76 | $0 |
PHVS
Pharvaris N.V. |
$17.55 | $843.31 M | -5.8 | 83 | $0 |
PMVP
PMV Pharmaceuticals, Inc. |
$1.36 | $85.40 M | -1.26 | 63 | $0 |
RZLT
Rezolute, Inc. |
$4.76 | $229.57 M | -5.02 | 59 | $0 |